NCT07411430 Peripheral Venous Access Management by Radiologic Technologists in Radiodiagnostic Procedure
| NCT ID | NCT07411430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Skill Development of Staff |
| Study Type | INTERVENTIONAL |
| Enrollment | 9 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 9 participants in total. It began in 2026-06-15 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this interventional study is to evaluate the impact of a structured training program on the ability of Radiologic Technologists (RTs) to safely and effectively perform peripheral venous access (PVA) placement for contrast media administration in a radiodiagnostic setting. The study focuses on adult patients undergoing contrast-enhanced imaging procedures and on Radiologic Technologists who have completed a competency-based theoretical and practical training program on peripheral venous access management. The main questions it aims to answer are: * Does a structured training program improve the theoretical knowledge and technical competencies of Radiologic Technologists in peripheral venous access placement? * What is the incidence of complications associated with peripheral venous access placement performed by trained Radiologic Technologists in routine clinical practice? * How do patients perceive the procedure in terms of pain, safety, procedural success, and overall satisfaction? Participants: * Radiologic Technologists will participate in a structured theoretical and practical training program focused on peripheral venous access placement for contrast media administration. * Radiologic Technologists will perform peripheral venous access placement during routine radiodiagnostic procedures following completion of the training. * Patients undergoing contrast-enhanced imaging will receive peripheral venous access placement performed by trained Radiologic Technologists and will complete questionnaires assessing pain, satisfaction, and perceived safety of the procedure.
Eligibility Criteria
Inclusion Criteria for Radiologic Technologists (RTs): * Voluntary participation and provision of written informed consent. * Completion of the structured theoretical and practical training program for peripheral venous access placement for contrast media administration. Inclusion Criteria for Patients: * Age ≥18 years * Provision of written informed consent. * Undergoing a contrast-enhanced CT or MRI examination requiring peripheral venous access placement for contrast media administration. Exclusion Criteria for Radiologic Technologists (RTs): \- No written informed consent. Exclusion Criteria for Patients: * Age \<18 years. * Severe cognitive impairment that precludes valid informed consent or completion of the patient survey. * No written informed consent. * Clinical conditions that make peripheral venous access placement complex or unsafe, as determined by the clinical team.
Contact & Investigator
Danilo Pasini
PRINCIPAL INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT07411430 clinical trial?
This trial is open to participants of all sexes, studying Skill Development of Staff. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07411430 currently recruiting?
Yes, NCT07411430 is actively recruiting participants. Contact the research team at danilo.pasini@policlinicogemelli.it for enrollment information.
Where is the NCT07411430 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT07411430 clinical trial?
NCT07411430 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Danilo Pasini at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 9 participants.